Media and Investors Resources
Press Release, 29 October 2019
Kuros convenes Extraordinary General Meeting
Press Release, 2 October 2019
Kuros Biosciences to Host Key Opinion Leader Meeting in Zurich Showcasing its Commercial Stage Advanced Bone Graft MagnetOs
Press Release, 24 September 2019
Kuros Biosciences announces full commercial launch of MagnetOs™ and exhibitor status at North American Spine Society 34 th Annual Meeting
Press Release, 3 September 2019
Kuros Biosciences Announces U.S. FDA approval of IND Application to Initiate Fibrin-PTH Phase 2a Clinical Trial in Spinal Fusion
Press Release, 20 August 2019
Kuros Biosciences Reports Results for First Half 2019
Kuros Interim Results, 2019
English version